IRIS
IANNUZZO, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.673
NA - Nord America 4.679
EU - Europa 3.858
SA - Sud America 723
Continente sconosciuto - Info sul continente non disponibili 227
AF - Africa 139
OC - Oceania 1
Totale 15.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.461
SG - Singapore 2.481
RU - Federazione Russa 1.728
CN - Cina 1.090
VN - Vietnam 1.075
IT - Italia 898
BR - Brasile 551
HK - Hong Kong 365
DE - Germania 348
FR - Francia 231
BD - Bangladesh 144
FI - Finlandia 143
NL - Olanda 134
GB - Regno Unito 108
CA - Canada 101
JP - Giappone 96
IN - India 89
AR - Argentina 65
KR - Corea 59
MX - Messico 57
IE - Irlanda 45
CI - Costa d'Avorio 44
TH - Thailandia 44
PH - Filippine 37
PL - Polonia 37
ZA - Sudafrica 35
UA - Ucraina 33
EC - Ecuador 31
AT - Austria 29
SE - Svezia 29
ID - Indonesia 27
IQ - Iraq 26
ES - Italia 23
VE - Venezuela 19
TR - Turchia 18
CO - Colombia 15
PK - Pakistan 15
CL - Cile 14
CH - Svizzera 13
JM - Giamaica 13
TW - Taiwan 12
MA - Marocco 11
NP - Nepal 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
KE - Kenya 9
LT - Lituania 9
MY - Malesia 9
SA - Arabia Saudita 9
JO - Giordania 8
PT - Portogallo 8
UZ - Uzbekistan 8
BE - Belgio 7
DZ - Algeria 7
EG - Egitto 7
NI - Nicaragua 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
HN - Honduras 6
IL - Israele 6
IR - Iran 6
PE - Perù 6
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
GT - Guatemala 5
OM - Oman 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
GR - Grecia 3
LB - Libano 3
PS - Palestinian Territory 3
SC - Seychelles 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BB - Barbados 2
BS - Bahamas 2
BZ - Belize 2
CG - Congo 2
CM - Camerun 2
CY - Cipro 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
KH - Cambogia 2
KZ - Kazakistan 2
LC - Santa Lucia 2
LY - Libia 2
MK - Macedonia 2
RO - Romania 2
SN - Senegal 2
SX - ???statistics.table.value.countryCode.SX??? 2
AM - Armenia 1
AU - Australia 1
Totale 15.055
Salva come PNG Salva come JPEG
Città #
Singapore 1.235
San Jose 870
Ashburn 486
Moscow 372
Hong Kong 354
Ho Chi Minh City 350
Chandler 309
Beijing 305
Hefei 263
Hanoi 232
Santa Clara 221
Naples 152
Council Bluffs 147
Munich 141
Los Angeles 124
Lauterbourg 121
Millbury 90
The Dalles 78
Boardman 75
Helsinki 75
Tokyo 75
Amsterdam 72
Phoenix 69
Boston 68
Buffalo 66
New York 58
Milan 55
Napoli 55
Rome 55
São Paulo 52
Lawrence 49
Des Moines 45
Princeton 44
Seoul 43
Haiphong 40
Redondo Beach 39
Frankfurt am Main 38
Da Nang 37
Dallas 36
Orem 31
Toronto 31
Nanjing 30
Turku 27
Dong Ket 26
Nuremberg 26
Wilmington 24
Rio de Janeiro 23
Seattle 23
Warsaw 23
Jacksonville 22
Mexico City 22
Montreal 21
Atlanta 20
Brooklyn 20
Denver 20
Bangkok 19
Dublin 19
Chicago 18
Falkenstein 18
Houston 18
Shanghai 18
Washington 18
Biên Hòa 17
Chennai 17
London 17
Marsala 16
Changsha 15
Hebei 15
Stockholm 15
Bologna 14
Brasília 14
Nanchang 14
San Francisco 14
Charlotte 13
Curitiba 13
Düsseldorf 13
Fairfield 13
Jiaxing 13
Krefeld 13
Ottawa 13
Genoa 12
Guangzhou 12
Hải Dương 12
Woodbridge 12
Xi'an 12
Guayaquil 11
Johannesburg 11
Manchester 11
Poplar 11
Quận Bình Thạnh 11
Vienna 11
Augusta 10
Baghdad 10
Bar Harbor 10
Mumbai 10
Portsmouth 10
Thái Bình 10
Buenos Aires 9
Can Tho 9
Dhaka 9
Totale 7.985
Salva come PNG Salva come JPEG
Nome #
Short-term treatment of iron deficiency anemia after cardiac surgery 281
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 271
Dyslipidemia in Transplant Patients: Which Therapy? 213
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 177
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 172
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 170
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 167
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 161
Atherogenic Lipoprotein Subfractions and Carotid Atherosclerosis in Menopausal Women 157
Apo B, Small-dense LDL and carotid atherosclerosis in menopausal women 156
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 156
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 154
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 153
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 151
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 150
Association between small dense LDL particles and early atherosclerosis in a sample of middle-aged women. Findings from Progetto Atena 149
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 148
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 148
Association between small dense LDL and early atherosclerosis in a sample of menopausal women. 147
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 147
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 144
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. 143
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 142
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 140
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 140
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 140
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 139
Predictive and prognostic markers in a cohort of Mediterranean women:review from Atena project 137
Carotid Atherosclerosis, Ultrasound and Lipoproteins 136
Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art 136
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia 136
Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women Without Overt Cardiovascular Disease and on LDL-C Target Levels. 135
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 134
New Ultrasound Technologies for Ischemic Heart Disease Assessment and Monitoring in Cardiac Rehabilitation 134
Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation 134
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features. 134
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 133
Effects of weight modification on hs-crp in a cohort of mediterranean women: findings from progetto atena. 130
Aterosclerosi preclinica 130
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 130
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 129
A height-weight formula to measure body fat in childhood obesity 128
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 128
Renal involvement in COVID-19: focus on kidney transplant sector 128
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 128
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 127
Screening for Familial Combined Hyperlipidemia criteria in a cohort of Mediterranean women: findings from Progetto ATENA 126
Iodine Requirements in Pediatrics: From Fetal Life to Adolescence 125
Association between body shape index and small dense LDL particles in a cohort of mediterranean women: Findings from Progetto ATENA 125
Creatinine levels and intima media thickness in a population based cohort study: finding from Progetto Atena. 124
More inflammation in Familial Hypercholesterolemia than in Familial Combined Hyperlipidemia. 124
Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome. 124
Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia. 123
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 123
Evinacumab for Homozygous Familial Hypercholesterolemia 123
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients 123
Inflammatory markers in Familial Combined Hyperlipidemia 122
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 122
Fat mass and vascular health in overweight/obese children 122
Exercise Training in Patients with Heart Failure: From Pathophysiology to Exercise Prescription 121
Exercise Training in Elderly Cancer Patients: A Systematic Review 120
ipotiroidismo subclinico ed aterosclerosi carotidea 120
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 120
The bone-heart axis in the pathogenesis of cardiovascular diseases: A narrative review 119
Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials 118
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 118
Familial Combined hyperlipidemia and IMT 118
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 117
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 117
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 116
Association between small dense ldl and cardiovascular events in Familial combined hyperlipidemia. 116
Biochemical Screening for Familial Combined Hyperlipidemia 116
Association between Lp(a) and small dense LDL in menopausal women without metabolic syndrome 116
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 116
Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction 115
Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin? 115
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 115
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement 114
Tumor Necrosis Factor-α is a marker of Familial Conbined Hyperlipidemia, independently of metabolic sindrome 113
Società per lo studio dell'aterosclerosi ( Sezione Campania) 112
Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events. 112
Tumor necrosis factor-α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome 111
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 111
Early carotid atherosclerosis in obesity and overweight is independent of hs-CRP in a cohort of mediterranean women: findings from Progetto Atena 110
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 109
The relationship between BMI and common carotid plaques or Apo B and bifurcation plaques are independent of hs-CPR concentration: findings from Progetto ATENA 108
Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia 108
Oltre le statine quale terapia per l'ipercolesterolemia: gli inibitori del pCSK9 e l'inclisiran 108
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 107
Carotid artery wall hypertrophy in children with metabolic syndrome 107
Relation of body mass index with carotid intima-media thickness and diameter is independent of metabolic syndrome in postmenopausal Mediterranean women. 107
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. 105
Aterosclerosi subclinica. influenza dei geni e dell' ambiente 105
Response to Letter to the Editor: "Association of Vitamin D Deficiency With Peripheral Arterial Disease: A Meta-Analysis of Literature Studies" 104
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients 104
Exercise for slowing the progression of atherosclerotic process: effects on inflammatory markers 103
Relation of body mass index with intima media thickness and diameters is independent of metabolic syndrome in post menopausal women. 102
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 101
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome 99
Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. 98
Totale 13.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022511 0 0 7 6 17 3 3 31 22 78 135 209
2022/2023807 97 57 37 46 96 85 5 81 113 71 93 26
2023/2024774 65 91 53 43 47 84 11 94 21 38 120 107
2024/20254.083 182 146 44 102 82 283 444 277 256 493 1.452 322
2025/20267.679 791 617 806 709 1.271 296 771 394 1.044 450 264 266
2026/2027800 225 315 260 0 0 0 0 0 0 0 0 0
Totale 15.300